Sort
34,240 grants matching “atherosclerosis”
Regulation of carbon utilization in gut-resident bacteria
$401,250Ashley Robin Wolf · University Of California Berkeley · R35 · FY2024 · GM
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2020 · HL
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2022 · HL
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2021 · HL
Apo E mimetics reduce cholesterol and improve HDL function
$401,221G M Anantharamaiah · University Of Alabama At Birmingham · R01 · FY2008 · HL
Diabetes, Cognition and the Brain
$401,185Antonio Convit · New York University School Of Medicine · R01 · FY2006 · DK
AMPK, Metabolic and Inflammatory Stress and the Endothelial Cell
$401,183Neil B Ruderman · Boston Medical Center · P01 · FY2010 · HL
SIRT1, Polyphenols, and Endothelial Oxidants
$401,180Richard A Cohen · Boston Medical Center · P01 · FY2010 · HL
Alternative routes of gut microbial methylamine metabolism that may limit trimethylamine N-oxide, a trigger for atherosclerosis.
$401,151Joseph Adrian Krzycki · Ohio State University · R01 · FY2019 · DK
HIV-1, Exercise and Endothelial Function
$401,130Christopher A Desouza · University Of Colorado · R01 · FY2011 · HL
Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates
$401,118Edward Lakatta · National Institute On Aging · ZIA · FY2013 · AG
Phage-inspired nanoparticles with genetically tunable target-specificity
$401,096Chuanbin Mao · University Of Oklahoma · R01 · FY2009 · HL
Interleukin-19 Inhibits Atherosclerosis by Diverse Mechanisms
$401,089Michael V Autieri · Temple Univ Of The Commonwealth · R01 · FY2013 · HL
CD14, Surfactant Proteins, and Vascular Inflammation
$401,067Neal L Weintraub · University Of Iowa · P01 · FY2010 · HL
Signal Transduction by Oxysterols
$401,054Rajat Rohatgi · Stanford University · R01 · FY2016 · GM
OXIDATIVE STRESS AND VASCULAR AGING
$401,022Marschall S. Runge · Univ Of North Carolina Chapel Hill · P01 · FY2007 · AG
GENETIC CONTROL OF PROTEOGLYCAN METABOLISM
$401,021Jeffrey D Esko · University Of California, San Diego · R37 · FY2007 · GM
Studies of Isoprenoid Bioisynthesis
$401,018Charles Dale Poulter · University Of Utah · R01 · FY2007 · GM
Roles of Endothelial PECAM-1 in Leukocyte Transmigration
$400,960Weill Medical College Of Cornell Univ · R01 · FY2004 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$400,950Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2019 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$400,950Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2017 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$400,950Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2018 · HL
The role of protease-activated receptor 2 in atherosclerosis
$400,938Albert Phillip Owens III · University Of Cincinnati · R01 · FY2019 · HL
CCR2 AND CCR5--ATHEROSCLEROSIS AND CONTROL OF EXPRESSION
$400,832J. David Gladstone Institutes · R01 · FY2000 · HL
Genetic Predisposition and Pharmacogenomics of HIV-Associated Cognitive Impairment
$400,773Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HG